WASHINGTON, Oct. 30, 2019 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will
release results for the third quarter 2019 and provide a general
business overview, on Wednesday, November 6,
2019, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, November 6, 2019, during which
management will discuss the third quarter 2019 financial results
and other corporate activities. To participate in the conference
call, please dial 1-866-688-9426 (domestic) or 1-409-216-0816
(international) and use passcode 5377942.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Wednesday, November 6, 2019, beginning at
7:30 PM ET and will be accessible
until Wednesday, November 13, 2019,
at 7:30 PM ET. The replay call-in
number is 1-855-859-2056 for domestic callers and 1-404-537-3406
for international callers. The passcode number is 5377942.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a leading
global biopharmaceutical company focused on the development and
commercialization of innovative therapies to address high unmet
medical needs and improve the lives of patients. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com.
Corporate Contact:
AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2019-financial-results-on-november-6-2019-300948543.html
SOURCE Vanda Pharmaceuticals Inc.